Paul oversees Arboretum’s investment process and leads the firm’s operations. His investments focus on capital-efficient medical device and health IT companies applying novel technologies to underserved markets. He currently serves as a board director for Allay Therapeutics, Navv Systems and Orasis Pharmaceuticals. He led Arboretum’s previous investments in Rethink Autism (acquired by K1) and BioIQ (acquired by LetsGetChecked) and is the former Chief Operating Officer for CerviLenz, where he led the design of the company’s first commercial product from concept to launch. 

Prior to Arboretum, Paul held management positions at Ford Motor Company within product development, manufacturing, and business strategy. He currently serves on the National Advisory Board for the Institute for Healthcare Policy & Innovation at the University of Michigan and is the treasurer and board director of the Michigan Venture Capital Association. 

Paul earned a BS and MS in Mechanical Engineering from the University of Michigan and an MBA from the Ross School of Business at the University of Michigan.